GlassScriptPhysician profile
Roger L Sur
NPI 1932208022
$356,255.52
in general payments reported to CMS, 2019-2025
28 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140K · 2020: $38K · 2021: $37K · 2022: $67K · 2023: $20K · 2024: $37K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Consulting Fee: $6,000 · Food and Beverage: $5,492 · Travel and Lodging: $3,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,405.00 |
| Consulting Fee | $6,000.00 |
| Food and Beverage | $5,491.79 |
| Travel and Lodging | $3,078.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $263,914.65 | 2019-2025 | Lumenis Pulse 120h, General - Kidney Stone Disease, General - Bph |
| Karl Storz Endoscopy-America | $27,327.31 | 2019-2023 | Hd-View, Hopkins |
| Cook Incorporated | $21,686.14 | 2019-2025 | S~Curve, Litho 150 |
| Travere Therapeutics, INC. | $10,916.31 | 2019-2022 | |
| Lumenis, INC | $8,419.24 | 2019-2021 | |
| Calyxo, INC. | $7,071.90 | 2022-2025 | Cvac Aspiration System |
| Ethicon INC. | $5,555.63 | 2019-2022 | |
| Ethicon Endo-Surgery INC. | $4,603.63 | 2022 | |
| Auris Health, INC. | $4,000.00 | 2019 | |
| Cook Medical LLC | $1,290.62 | 2019-2025 | Litho 150, Fiber Dust, S~Curve |
| Procept Biorobotics Corporation | $324.26 | 2020-2025 | Aquabeam Robotic System |
| Histosonics, INC. | $171.61 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $136.15 | 2023 | Bard Urinary Drainage Bag |
| Dornier Medtech America, INC | $133.31 | 2019 | |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $108.24 | 2019-2025 | Gentlecath Glide |
| Coloplast Corp | $80.63 | 2022-2025 | |
| Ambu INC. | $69.45 | 2025 | |
| Merck Sharp & Dohme LLC | $65.48 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Novo Nordisk INC | $49.90 | 2025 | Rivfloza |
| Profound Medical Corp. | $42.30 | 2025 | Tulsa-Pro |
| Cycle Pharmaceuticals INC | $41.92 | 2025 | Venxxiva |
| Richard Wolf Medical Instruments Corp. | $28.95 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.09 | 2019 | |
| Abc Home Medical Supply, INC. | $23.13 | 2025 | |
| Blue Earth Diagnostics | $21.76 | 2024 | |
| Becton, Dickinson and Company | $16.12 | 2023 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$142,800.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Sur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.